10.3.4Segment

Healthcare & Life Sciences Logistics

Specialized logistics services for the regulated, time-critical movement of pharmaceutical products, clinical trial materials, medical devices, and biological specimens under chain-of-custody.

5
Verticals

Overview

Healthcare & Life Sciences Logistics covers the specialized logistics for medical and pharmaceutical products — the storage, handling, and distribution of drugs, biologics, medical devices, and clinical-trial materials under strict regulatory, security, and cold-chain requirements. It is provided by specialized healthcare logistics units (UPS Healthcare, FedEx, McKesson, Cardinal) and dedicated pharma-logistics firms.

Demand is driven by pharmaceutical growth, the rise of temperature-sensitive biologics and cell-and-gene therapies (requiring ultra-cold and precise handling), and stringent compliance (chain of custody, serialization), making it a high-value, high-barrier specialty. It is consolidating around scaled, compliant providers, with cold-chain integrity, regulatory expertise, and security the key capabilities; biologics and specialty pharma are the growth drivers.

Market snapshot

FragmentationConsolidating

Healthcare and life-sciences logistics span warehousing, transport, and distribution activities and overlap pharmaceutical distribution (profiled under Distribution & Wholesale Trade); it is not separately disclosed, so the segment is not separately sized here.

Business model & economics

Revenue model
Specialized healthcare-logistics and cold-chain fees
Recurring revenue
High — recurring pharma/medical logistics
EBITDA margin
Strong — high-barrier specialty economics
Capex intensity
Moderate
  • Regulated storage and distribution of drugs/biologics.
  • Biologics and cell/gene therapy drive cold-chain demand.
  • Compliance, cold-chain, and security the key capabilities.

M&A deal context

High deal activity

Who’s acquiring

Healthcare-logistics specialistsCarriers (UPS/FedEx Healthcare)PE-backed pharma-logistics platforms

What’s driving deals

  • Biologics and specialty-pharma growth.
  • Cold-chain and compliance demand.
  • Specialized-logistics consolidation.

Verticals in this segment

  • 10.3.4.1Biologic & Cell Therapy Logistics

    Ultra-cold and controlled-room-temperature logistics providers managing the complex chain-of-custody requirements for biologics, CAR-T therapies, and advanced medicinal products.

  • 10.3.4.2Clinical Trial & Investigational Drug Logistics

    GDP-compliant logistics providers managing global distribution of investigational medicinal products, comparators, and ancillary supplies for Phase I-IV clinical trials.

  • 10.3.4.3Hospital & Health System Supply Chain

    Integrated supply chain and logistics services managing inventory replenishment, sterile processing support, and materials management for hospital and health system networks.

  • 10.3.4.4Medical Device & Capital Equipment Logistics

    Logistics providers managing the delivery, installation, and return of medical devices, surgical instruments, diagnostic equipment, and capital healthcare equipment.

  • 10.3.4.5Pharmaceutical Distribution & Wholesale Delivery

    Specialty distributors delivering prescription pharmaceuticals, biologics, and specialty drugs from manufacturers to hospitals, pharmacies, and healthcare providers.

Find Healthcare & Life Sciences Logistics acquisition targets

Search Acquisera’s index for companies classified under Healthcare & Life Sciences Logistics (10.3.4) and build a targeted deal pipeline.

Search companies